Accuracy of allometrically predicted pharmacokinetic parameters in humans: Role of species selection

被引:28
作者
Tang, HD [1 ]
Mayersohn, M [1 ]
机构
[1] Univ Arizona, Coll Pharm, Dept Pharmaceut Sci, Tucson, AZ 85721 USA
关键词
D O I
10.1124/dmd.105.004127
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A general equation was derived, which directly describes the mathematical relationship between the allometrically predicted pharmacokinetic (PK) parameters in humans and the body weights of animal species (along with their corresponding measured PK parameters). It was shown, with use of the derived equation, that the predicted values in humans, based on combinations of animal species commonly used in allometry, are heavily dependent on certain species, for example, the dog. In contrast, parameter values from the rat made no contribution to the predicted human values, as long as the rat was not the smallest species used. Monte Carlo simulations were further performed to examine the species or weight dependence. The cost-effective combinations of animal species, in terms of number and species type, were theoretically examined through simulations. Finally, literature data demonstrated the species or weight dependence predicted from the equation and as illustrated through the Monte Carlo simulations. Appreciation of this species or weight dependence should guide researchers in selecting animal species and designing optimal experiments in the application of allometric scaling.
引用
收藏
页码:1288 / 1293
页数:6
相关论文
共 41 条
[1]   SCALING OF ANTIPYRINE INTRINSIC CLEARANCE OF UNBOUND DRUG IN 15 MAMMALIAN-SPECIES [J].
BOXENBAUM, H ;
FERTIG, JB .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1984, 9 (02) :177-183
[2]   INTERSPECIES SCALING, ALLOMETRY, PHYSIOLOGICAL TIME, AND THE GROUND PLAN OF PHARMACOKINETICS [J].
BOXENBAUM, H .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1982, 10 (02) :201-225
[3]  
Busch U, 1998, DRUG METAB DISPOS, V26, P576
[4]   INTERSPECIES PHARMACOKINETIC SCALING OF SCH-34343 [J].
CHUNG, M ;
RADWANSKI, E ;
LOEBENBERG, D ;
LIN, CC ;
ODEN, E ;
SYMCHOWICZ, S ;
GURAL, RP ;
MILLER, GH .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1985, 15 :227-233
[6]   Allometric pharmacokinetic scaling: Towards the prediction of human oral pharmacokinetics [J].
Feng, MR ;
Lou, XC ;
Brown, RR ;
Hutchaleelaha, A .
PHARMACEUTICAL RESEARCH, 2000, 17 (04) :410-418
[7]   INTERSPECIES SCALING AND PHARMACOKINETIC PARAMETERS OF 3TC IN HUMANS [J].
HUSSEY, EK ;
DONN, KH ;
DANIEL, MJ ;
HALL, ST ;
HARKER, AJ ;
EVANS, GL .
JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 34 (10) :975-977
[8]   Comparative pharmacokinetics and interspecies scaling of amphotericin B in several mammalian species [J].
Hutchaleelaha, A ;
Chow, HH ;
Mayersohn, M .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1997, 49 (02) :178-183
[9]   Formation and pharmacokinetics of the active drug candoxatrilat in mouse, rat, rabbit, dog and man following administration of the prodrug candoxatril [J].
Kaye, B ;
Brearley, CJ ;
Cussans, NJ ;
Herron, M ;
Humphrey, MJ ;
Mollatt, AR .
XENOBIOTICA, 1997, 27 (10) :1091-1102
[10]  
Khor SP, 1997, CANCER CHEMOTH PHARM, V39, P233